Prof Fairen-Jimenez, CSO of Vector Bioscience Cambridge and Professor of Molecular Engineering at the University of Cambridge ...

Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...

Data demonstrates sustained clinical improvements in pain, stiffness and function for up to 156 weeks following a single ...

Prescient investors who participated in Immaterial’s £13.5million Series A2 funding round will be delighted that the advanced ...

Ginkgo Bioworks announced today that it has been awarded a contract through the Biomedical Advanced Research and Development Authority's (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium ...

Learn more about whether BioMarin Pharmaceutical Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Detailed price information for Pacira Pharm Inc (PCRX-Q) from The Globe and Mail including charting and trades.

AI-powered vector design and preclinical validation mark the first step in a multi-phase program aimed at accelerating the path from discovery to clinical assessment in Alzheimer's disease. AUSTIN, TX ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: 4 Clinical-Stage Biotechs to Watch as the Sector Rebounds (MDCX, AUPH, LEXX, EDSA) ...

Ferring Pharmaceuticals announced today that three abstracts featuring ADSTILADRIN® (nadofaragene firadenovec-vncg) will be presented at the 101st Annual Meeting of the Western Section of the American ...

Climate change continues to alter pest and disease dynamics across Africa, leading to the emergence of new and invasive pests ...

He is chairman of the board of Chiara Biosciences. He also serves on the board of several ... In recognition of his contributions to viral vector–based therapeutics and translation, Dr. Curiel was ...